Pharma-delics? UCSF Kicks Off First-Ever Trial of Drug Naturally Derived From Magic Mushrooms

Innovative trial will use psilocybin to target relapse in opioid addiction

Filament Health Announces Issuance Of Common Shares To Negev Capital Investments Limited Pursuant To Advisory Agreement

Filament Health Announces Second Quarter 2024 Financial Results And Operational Highlights